Although it's based in neutral Switzerland, Novartis has been aggressive in attacking illnesses on multiple fronts, including pharmaceuticals and vaccines. One of the world's largest pharmaceuticals, the company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars, and ophthalmic products. The company's Innovative Medicines segment develops and manufactures prescription drugs for blood pressure, cancer, and other ailments. Its Sandoz segment is among the largest manufacturers of generic drugs in the world; it also makes APIs. Novartis generates most of its revenue from international customers.
See detailed business credit reports on other businesses or your own.
See detailed profiles for insights and prospects on this company's top competitors.
Essential information for a successful call
EMPLOYEES (This Site)
EMPLOYEES (All Sites)
- ASSETS (MIL USD) 132,059
REVENUE (MIL USD)
- TICKER SYMBOL NOVN
- Year Started 1885
- Incorporated 1996
- FISCAL YEAR END DEC
- SALES GROWTH % 2.51%
Similar Companies Nearby
Get in Touch with 28 Principals*
Vasant Kalathur NarasimhanManaging Director and Chairperson
Hans Jörg ReinhardtChairman of the Board
Enrico VanniVice Chairman of the Board
Anthonius Christianus Maria Augustinus BüchnerMember of the Board of Directors